Board-certified dermatologist and anti-aging specialist with over a decade of clinical and research leadership. Dr. Park combines expertise in laser systems, injectable aesthetics, thread-lift techniques, and regenerative therapies to deliver evidence-based protocols that prioritize patient safety, comfort, and natural, lasting outcomes. A sought-after educator and consultant, he has trained hundreds of clinicians and guided protocol development for leading medical device and biotech firms.
Dermatology Residency, Seoul National University Hospital
Advanced training in laser therapies, injectables, and anti-aging procedures
Medical Student Summer Program, Samsung Medical Center (Sungkyunkwan Univ.)
KSKCS Non-invasive Cosmetic Surgery Course
KCCS Asian Lipoplasty Workshop
Founder, CEO & Medical Director, BioFace Clinic (2018–Present)
Lead all clinical operations, research initiatives, and strategic growth both domestically and internationally.
QOFill Filler Educator, JW Pharmaceutical (2016–Present)
Deliver hands-on workshops on safe, precise filler injection techniques to over 300 physicians nationwide.
HIFU Lifting Technology Consultant (2017–Present)
Advise device manufacturers on protocol optimization to maximize lift efficacy while minimizing downtime.
Clinical Advisor, L&C BIO (KOSDAQ-listed) (2019–Present)
Design and analyze clinical trials for novel dermatologic injectables.
Clinical Advisor, UTI (Application Specialist)
Provide scientific support and training for UTI’s aesthetic device portfolio.
Technical Consultant, NewThera
Guide R&D and protocol development for next-generation aesthetic injectables.
Invited Speaker, Medical Asia 2016
“Next-Generation Filler Strategies” presented to 500+ regional aesthetic practitioners.
Key Publication:
Kim JW, Li MH, Jang JH, et al.
15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Biochem Pharmacol. 2008;76(11):1577–1589.
Korean Academy of Laser Medicine
World Society for Laser Medicine & Surgery
Korean Society for Hair Research
Korean Society of Anti-Aging Dermatology
Korean Society of Obesity & Aesthetic Treatment
Korean Society of Obesity & Body Shaping
Korean Society for Stem Cell Therapy
Korean Society of Primary Care
Developed research-driven, multi-modal anti-aging protocols integrating lasers, injectables, thread lifts, and stem-cell boosters.
Trained 300+ physicians in advanced filler and HIFU applications, elevating national standards of care.
Received the Korean Society of Aesthetic Medicine’s Excellence in Education Award.
Served as medical advisor on KBS health documentary series and multiple international media features.
Evidence-Based Protocols: Continuous refinement through outcome analysis of thousands of patient cases
Integrated Anti-Aging: Holistic treatment plans tailored for minimal discomfort and rapid recovery
Educational Leadership: Curriculum design and delivery for clinician workshops and medical symposia
Strategic Consulting: Product development guidance for device manufacturers and biotech firms
Languages: Korean (native), English (fluent)
Continuing Education: Regular faculty at international conferences; numerous peer-reviewed publications in leading dermatology journals.
Read more
Dr. Jung Young Choon is a board-certified plastic surgeon and the Founder and Head Surgeon of HERSHE Plastic Surgery Korea, one of Seoul’s most respected plastic surgery clinics specializing in anti-aging, contouring, and stem cell-based regenerative procedures. With an extensive academic background and decades of clinical experience, Dr. Jung is widely recognized in both domestic and international medical communities as a leader in the field of aesthetic surgery.
Throughout his career, Dr. Jung has become a leading specialist in anti-aging surgeries, such as facelifts, MACS lifts, thread lifts, and fat grafting for both the face and body. His skillset also extends to body contouring and body filler procedures, where he is known for his meticulous technique and artistry in creating subtle, elegant transformations that enhance natural anatomy rather than alter it. His work emphasizes individualized treatment, tailoring every procedure to each patient’s unique facial and body structure, concerns, and aesthetic goals.
HERSHE Plastic Surgery has secured patents for the process of producing and cultivating growth factors from adipose-derived stem cells, ensuring a scientifically validated and proprietary approach to regenerative medicine. With this technology, Dr. Jung and his research team have created a suite of personalized stem cell-based programs, including Adipose-derived stem cells (ADSCs) program and SVF (Stromal Vascular Fraction) program.
Dr. Jung's reputation is not only built on his academic credentials or technical skills, but also on the results he delivers. Patients from all over the world visit HERSHE seeking his expertise, especially for procedures that demand refined results, such as natural-looking facelifts, balanced facial fat grafts, youth-restoring thread lifts, and body contouring treatments. His aesthetic approach is conservative yet impactful, always striving to enhance rather than change, and to restore rather than overcorrect.
From surgical anti-aging procedures to the latest advancements in stem cell-based rejuvenation, Dr. Jung Young Choon continues to lead with precision, compassion, and a clear vision for the future of aesthetic medicine.
Read more•Certified Teaching Specialist, Korean Hospital Association
•Certified Teaching Specialist, Korean Society of Plastic and Reconstructive Surgeons
•Full Member, Korean Society of Plastic and Reconstructive Surgeons (KSPRS)
•Full Member, Korean Society for Aesthetic Plastic Surgery (KSAPS)
•Full Member, Korean Cleft Palate-Craniofacial Association (KCPCA)
•Full Member, Korean Society for Medical Laser Medicine and Surgery
•Former Director, Planner Plastic Surgery Clinic
Read more
Key International Publication
Kim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.
“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”
Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.
International Conference Presentations
The International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, Korea
The 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, Thailand
Domestic Conference Presentations
The Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, Korea
The 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, Korea
The 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, Korea
The 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, Korea
The Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea
Read more